Abstract
Hydrogen breath tests are widely used to explore pathophysiology of functional gastrointestinal (GI) disorders. Small intestinal bacterial overgrowth (SIBO) and carbohydrate malabsorption are disorders detected by these tests that have been proposed to be of great importance for symptoms of GI diseases. Glucose hydrogen breath test is more acceptable for diagnosis of SIBO whereas lactose and fructose hydrogen breath tests are used for detection of lactose and fructose maldigestion respectively. Lactulose hydrogen breath test is also used widely to measure the orocecal transit time for GI motility. These methods are noninvasive and inexpensive. Many patients with functional gut disorders are unaware of the relationship between diet and GI symptoms they present. In particular, patients with chronic symptoms may regard their condition as normal and may not be aware that their symptoms can be effectively managed following a proper diagnosis. Patients with symptoms of abdominal pain, bloating, flatulence and altered bowel movements (diarrhea and constipation), or with a medical diagnosis of irritable bowel syndrome or celiac disease, may have undiagnosed carbohydrate malabsorption or SIBO. Hydrogen breath tests are specific and sensitive diagnostic tests that can be used to either confirm or eliminate the possibility of carbohydrate malabsorption or SIBO in such patients. Breath tests, though valuable tools, are underutilized in evaluating dyspepsia and functional bloating and diarrhea as well as suspected malabsorption. However, because of their simplicity, reproducibility and safety of procedure they are now being substituted to more uncomfortable and expensive techniques that were traditionally used in gastroenterology.
Similar content being viewed by others
References
Harger RN, Forney RB, Barnes HB. Estimation of the level of blood alcohol from the analysis of breath. In: First international conference on alcohol and traffic, Stockholm, Sweden; 1950. pp. 107–21.
Borkenstein RF, Smith H. The breathalyzer and its application. Med Sci Law. 1961;2:13–22.
Pauling L, Robinson AB, Teranishi R, Cary P. Quantitative analysis of urine vapor and breath by gas–liquid partition chromatography. Proc Natl Acad Sci USA. 1971;68:2374–6.
Newcomer AD, McGill DB, Thomas PJ, Hofmann AF. Prospective comparison of indirect methods for detecting lactase deficiency. N Engl J Med. 1975;293:1232–6.
Bond JH, Levitt MD. Effect of dietary fiber on intestinal gas production and small bowel transit time in man. Am J Clin Nutr. 1978;31(10 Suppl):S169–74.
Bond JH, Levitt MD. Use of breath hydrogen (H2) to quantitate small bowel transit time following partial gastrectomy. J Lab Clin Med. 1977;90:30–6.
Srinivasan R, Minocha A. When to suspect lactose intolerance; symptomatic, ethnic, and laboratory clues. Postgrad Med. 1998;104:109–23.
Solomons NW, García-Ibañez R, Viteri FE. Hydrogen breath test of lactose absorption in adults: the application of physiological doses and whole cow’s milk sources. Am J Clin Nutr. 1980;33:545–54.
Rana S, Bhasin DK, Gupta D, Mehta SK. Assessment of optimal dose of lactose for lactose hydrogen breath test in Indian adults. Indian J Gastroenterol. 1995;14:13–4.
Qiao R, Hung CY, Zeng G, Vonk RJ, Li L, Ye S. Study on the lowest acceptable intake of cow’s milk for healthy adults. Wei Sheng Yan Jiu. 2006;35:747–9.
Levitt MD, Engel RR. Intestinal gas. Adv Intern Med. 1975;20:151–65.
Oberacher M, Pohl D, Vavricka SR, Fried M, Tutuian R. Diagnosing lactase deficiency in three breaths. Eur J Clin Nutr. 2011;65:614–8.
Rana SV, Bhasin DK, Naik N, Subhiah M, Ravinder P. Lactose maldigestion in different age groups of north Indians. Trop Gastroenterol. 2004;25:18–20.
Yang Y, He M, Cui H, Bian L, Wang Z. The prevalence of lactase deficiency and lactose intolerance in Chinese children of different ages. Chin Med J (Engl). 2000;113:1129–32.
Gupta D, Ghoshal UC, Misra A, Misra A, Choudhuri G, Singh K. Lactose intolerance in patients with irritable bowel syndrome from northern India: a case–control study. J Gastroenterol Hepatol. 2007;22:2261–5.
Rana SV, Mandal AK, Kochhar R, Katyal R, Singh K. Lactose intolerance in different types of irritable bowel syndrome in north Indians. Trop Gastroenterol. 2001;22:202–4.
Babu J, Kumar S, Babu P, Prasad JH, Ghoshal UC. Frequency of lactose malabsorption among healthy southern and northern Indian populations by genetic analysis and lactose hydrogen breath and tolerance tests. Am J Clin Nutr. 2010;91:140–6.
Kochhar R, Mehta SK, Goenka MK, Mukherjee JJ, Rana SV, Gupta D. Lactose intolerance in idiopathic ulcerative colitis in north Indians. Indian J Med Res. 1993;98:79–82.
Cabrera-Acosta GA, Milke-García MP, Ramírez-Iglesias MT, Uscanga L. Deficient lactose digestion and intolerance in a group of patients with chronic nonspecific ulcerative colitis: a controlled, double-blind, cross-over clinical trial. Rev Gastroenterol Mex. 2012;77:26–30.
Ginard D, Riera J, Bonet L, Barranco L, Reyes J, Escarda A, et al. Lactose malabsorption in ulcerative colitis. A case–control study. Gastroenterol Hepatol. 2003;26:469–74.
Skoog SM, Bharucha AE, Zinsmeister AR. Comparison of breath testing with fructose and high fructose corn syrups in health and IBS. Neurogastroenterol Motil. 2008;20:505–11.
Andersson DE, Nygren A. Four cases of long-standing diarrhoea and colic pains cured by fructose-free diet—a pathogenetic discussion. Acta Med Scand. 1978;203:87–92.
Nelis GF, Vermeeren MA, Jansen W. Role of fructose-sorbitol malabsorption in the irritable bowel syndrome. Gastroenterology. 1990;99:1016–20.
Symons P, Jones MP, Kellow JE. Symptom provocation in irritable bowel syndrome. Effects of differing doses of fructose–sorbitol. Scand J Gastroenterol. 1992;27:940–4.
Rao SSC, Attaluri A, Anderson L, Stumbo P. The ability of the normal human small intestine to absorb fructose: evaluation by breath testing. Clin Gastroenterol Hepatol. 2007;5:959–63.
Densupsoontorn N, Jirapinyo P, Thamonsiri N, Wongarn R. Fructose malabsorption in Thai adult. Asia Pac J Clin Nutr. 2007;16:209–12.
Reyes-Huerta JU, de la Cruz-Patiño E, Ramírez-Gutiérrez de Velasco A, Zamudio C, Remes-Troche JM. Fructose intolerance in patients with irritable bowel syndrome: a case–control study. Rev Gastroenterol Mex. 2010;75:405–11.
Metz G, Gassull MA, Drasar BS, Jenkins DJ, Blendis LM. Breath-hydrogen test for small-intestinal bacterial colonisation. Lancet. 1976;1(7961):668–9.
Posserud I, Stotzer PO, Björnsson ES, Abrahamsson H, Simrén M. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut. 2007;56:802–8.
Pimentel M, Park S, Mirocha J, Kane SV, Kong Y. The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med. 2006;145:557–63.
Rana SV, Sinha SK, Sikander A, Bhasin DK, Singh K. Study of small intestinal bacterial overgrowth in North Indian patients with irritable bowel syndrome: a case control study. Trop Gastroenterol. 2008;29:23–5.
Yakoob J, Abbas Z, Khan R, Hamid S, Awan S, Jafri W. Small intestinal bacterial overgrowth and lactose intolerance contribute to irritable bowel syndrome symptomatology in Pakistan. Saudi J Gastroenterol. 2011;17:371–5.
Sachdeva S, Rawat AK, Reddy RS, Puri AS. Small intestinal bacterial overgrowth (SIBO) in irritable bowel syndrome: frequency and predictors. J Gastroenterol Hepatol. 2011;26(Suppl 3):135–8.
Ghoshal UC, Kumar S, Mehrotra M, Lakshmi C, Misra A. Frequency of small intestinal bacterial overgrowth in patients with irritable bowel syndrome and chronic non-specific diarrhea. J Neurogastroenterol Motil. 2010;16:40–6.
Reddymasu SC, Sostarich S, McCallum RW. Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors? BMC Gastroenterol. 2010;10:23.
Rana SV, Sinha SK, Lal S, Sikander A, Singh K. Small intestinal bacterial overgrowth in North Indian patients with celiac disease. Trop Gastroenterol. 2007;28:159–61.
Ghoshal UC, Ghoshal U, Misra A, Choudhuri G. Partially responsive celiac disease resulting from small intestinal bacterial overgrowth and lactose intolerance. BMC Gastroenterol. 2004;4:10.
Tursi A, Brandimarte G, Giorgetti G. High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am J Gastroenterol. 2003;98:839–43.
Yang CY, Chang CS, Chen GH. Small-intestinal bacterial overgrowth in patients with liver cirrhosis, diagnosed with glucose H2 or CH4 breath tests. Scand J Gastroenterol. 1998;33:867–71.
Morencos FC, de las Heras Castaño G, Martín Ramos L, López Arias MJ, Ledesma F, Pons Romero F. Small bowel bacterial overgrowth in patients with alcoholic cirrhosis. Dig Dis Sci. 1995;40:1252–6.
Gupta A, Dhiman RK, Kumari S, Rana SV, Agarwal R, Duseja A, et al. Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy. J Hepatol. 2010;53:849–55.
Rana SV, Sharma S, Kaur J, Sinha SK, Singh K. Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Digestion. 2012;85:243–7.
Usai P, Usai Satta P, Lai M, Corda MG, Piras E, Calcara C, et al. Autonomic dysfunction and upper digestive functional disorders in untreated adult coeliac disease. Eur J Clin Invest. 1997;27:1009–15.
Giorgetti GM, Tursi A, Brandimarte G, Rubino E, Gasbarrini G. Dysmotility-like dyspeptic symptoms in coeliac patients: role of gluten and Helicobacter pylori infection. Dig Liver Dis. 2000;32:73–4.
Rana SV, Sharma S, Sinha SK, Prasad KK, Bhasin DK, Singh K. Orocecal transit time in patients with celiac disease from North India: a case control study. Trop Gastroenterol. 2008;29:98–100.
Chiarioni G, Bassotti G, Germani U, Battaglia E, Brentegani MT, Morelli A, et al. Gluten-free diet normalizes mouth-to-cecum transit of a caloric meal in adult patients with celiac disease. Dig Dis Sci. 1997;42:2100–5.
Rana SV, Kochhar R, Pal R, Nagi B, Singh K. Orocecal transit time in patients in the chronic phase of corrosive injury. Dig Dis Sci. 2008;53:1797–800.
Rana SV, Sinha SK, Prasad KK, Sharma SK, Kaur J, Rana SS, et al. W1838 Orocecal transit time and small intestinal bacterial overgrowth in patients with microscopic colitis. Gastroenterology. 2010;138:S-750.
Cuoco L, Montalto M, Jorizzo RA, Santarelli L, Arancio F, Cammarota G, et al. Eradication of small intestinal bacterial overgrowth and orocecal transit in diabetics. Hepatogastroenterology. 2002;49:1582–6.
Rana S, Bhansali A, Bhadada S, Sharma S, Kaur J, Singh K. Orocecal transit time and small intestinal bacterial overgrowth in type 2 diabetes patients from North India. Diabetes Technol Ther. 2011;13:1115–20.
Faria M, Pavin EJ, Parisi MC, Lorena SL, Brunetto SQ, Ramos CD, et al. Delayed small intestinal transit in patients with long-standing type 1 diabetes mellitus: investigation of the relationships with clinical features, gastric emptying, psychological distress, and nutritional parameters. Diabetes Technol Ther. 2013;15:32–8.
Heaton KW, Emmett PM, Symes CL, Braddon FE. An explanation for gallstones in normal-weight women: slow intestinal transit. Lancet. 1993;341(8836):8–10.
Rana SV, Kaur J, Gupta R, Gupta V, Rana SS, Bhasin DK. Su1190 Effect of cholecystectomy on orocecal transit time and small intestinal bacterial overgrowth in patients with gallstones. Gastroenterology. 2012;142(5)(Suppl 1):S-447.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rana, S.V., Malik, A. Hydrogen Breath Tests in Gastrointestinal Diseases. Ind J Clin Biochem 29, 398–405 (2014). https://doi.org/10.1007/s12291-014-0426-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-014-0426-4